logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울남부지방법원 2019.10.25 2018가단240053
손해배상(의)
Text

1. Each of the plaintiffs' claims is dismissed.

2. The costs of lawsuit are assessed against the plaintiffs.

Reasons

1. Basic facts

A. The relevant Plaintiffs are the successors as children of the network D (hereinafter “the deceased”), and the Defendant is the employer of the medical staff of the Defendant Hospital as a juristic person operating the hospital E (hereinafter “Defendant Hospital”).

(b) at the time of hospitalization of the Deceased (2017.7. 31) - From 2015 to 2015, diagnosis of bachpremathy xaty and marcophy, and registration of special cases for the calculation of health insurance: (a) - Carcurology and pulmonary CO2 high CO2 high level after the diagnosis of the Deceased’s hospitalization; (b) NIV (Dysthala; (c) - Infectic 6 Emorcurine 2) - Infectic pulmonary treatment of the Deceased’s disease at the time of 2015; and (c) n IV (n-invas’s vegetable; (dysthala); and (d) 6) Emoric pulmonary treatment of the Deceased’s disease; and (d) 4) an artificial pulmonary disease; and (d) an artificial pulmonary - Emoric - an animal therapy.

On September 14, 2017, death of the deceased, the oxygen intensity of the Deceased was lowered to 67%, and the blood pressure was reduced to 47mHg/30mHg.

arrow